{"ticker": {"uuid": "c20e95b0-db56-4a3a-8ca2-ee3062856362", "symbol": "MDXH", "name": "MDxHealth SA ADR", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "AWM amendment: no MDxHealth holdings reported (MDXH)", "summary": "AWM Investment Company, Inc. has filed an amendment to a Schedule 13G/A, reporting that it holds no beneficial ownership in MDxHealth (MDXH). The filing indicates that AWM and its associated funds own 0 shares, representing 0% of the class of Common Stock, No Par Value (CUSIP B59", "url": "https://www.stocktitan.net/sec-filings/MDXH/schedule-13g-a-m-dx-health-sa-amended-passive-investment-disclosure-a7e70e1e04f3.html", "source_name": "Stock Titan", "published_at": "2026-07-08T20:09:58", "published_display": "08 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of MDxHealth SA \u2013 NASDAQ:MDXH", "summary": "This article provides financial information for MDxHealth SA (NASDAQ: MDXH), focusing on its enterprise value to revenue forward metric. The content highlights the availability of financial data through TradingView, noting market status and data sources. It appears to be a stub o", "url": "https://www.tradingview.com/symbols/NASDAQ-MDXH/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T19:43:12", "published_display": "07 Jul 2026 19:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA explores US growth opportunities as diagnostics demand evolves", "summary": "MDxHealth SA, a molecular diagnostics company specializing in urology and prostate cancer testing, is focused on expanding its presence in the US market. The company seeks to increase the adoption of its diagnostic assays among physicians and health systems to support precision m", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/mdxhealth-sa-explores-us-growth-opportunities-as-diagnostics-demand/69714934", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T14:40:19", "published_display": "07 Jul 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of MDxHealth SA \u2013 NASDAQ:MDXH", "summary": "This article provides financial data for MDxHealth SA (NASDAQ: MDXH), specifically its price-to-book forward ratio. The content is presented within the context of TradingView's market analysis platform, indicating that the information is part of a larger financial overview for th", "url": "https://www.tradingview.com/symbols/NASDAQ-MDXH/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T04:40:34", "published_display": "05 Jul 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of MDxHealth SA \u2013 NASDAQ:MDXH", "summary": "The article focuses on the \"Price to sales forward\" metric for MDxHealth SA, traded on NASDAQ under the symbol MDXH. It appears to be a financial data snippet from TradingView, highlighting this specific financial ratio for the company. The content primarily lists navigation and ", "url": "https://www.tradingview.com/symbols/NASDAQ-MDXH/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T02:10:35", "published_display": "05 Jul 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency", "summary": "Mdxhealth SA announced it received a notification from Nasdaq due to non-compliance with the minimum bid price requirement of US$1.00 per share. The company has 180 calendar days, until December 28, 2026, to regain compliance by having its shares close at or above US$1.00 for at ", "url": "https://www.manilatimes.net/2026/07/03/tmt-newswire/globenewswire/mdxhealth-announces-receipt-of-nasdaq-notification-regarding-minimum-bid-price-deficiency/2377799", "source_name": "The Manila Times", "published_at": "2026-07-03T16:40:51", "published_display": "03 Jul 2026 16:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mdxhealth receives NASDAQ non-compliance notice after $1 bid price breach", "summary": "Mdxhealth (MDXH) has received a notice from NASDAQ for non-compliance with its minimum bid price requirement, as its stock traded below $1 for 30 consecutive business days. The company has 180 calendar days, until June 30, 2024, to regain compliance by ensuring its stock trades a", "url": "https://www.msn.com/en-us/money/companies/mdxhealth-receives-nasdaq-non-compliance-notice-after-1-bid-price-breach/ar-AA275NiY?ocid=finance-verthp-feeds", "source_name": "MSN", "published_at": "2026-07-02T22:39:26", "published_display": "02 Jul 2026 22:39", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth Gets Nasdaq Non-Compliance Notice", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/mdxhealth-gets-nasdaq-non-compliance-201243372.html", "source_name": "MT Newswires", "published_at": "2026-07-02T20:12:43+00:00", "published_display": "02 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nasdaq warns mdxhealth (NASDAQ: MDXH) on $1 bid rule, eyes reverse split", "summary": "Mdxhealth (NASDAQ: MDXH) has received a notice from Nasdaq for non-compliance with the minimum $1.00 bid price requirement, as its shares traded below this threshold for 30 consecutive days. The company has 180 calendar days, until December 28, 2026, to regain compliance by maint", "url": "https://www.stocktitan.net/sec-filings/MDXH/6-k-m-dx-health-sa-current-report-foreign-issuer-dc1475b28776.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:39:26", "published_display": "02 Jul 2026 20:39", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mdxhealth gets 180 days to fix Nasdaq bid-price issue", "summary": "Mdxhealth (NASDAQ: MDXH) received a Nasdaq notification on New Year's Eve 2026, indicating its shares no longer meet the US$1.00 minimum bid price requirement for continued listing. The company has 180 days, until December 28, 2026, to regain compliance, and may consider options ", "url": "https://www.stocktitan.net/news/MDXH/mdxhealth-announces-receipt-of-nasdaq-notification-regarding-minimum-3x328ywzexo6.html", "source_name": "Stock Titan", "published_at": "2026-07-02T19:39:26", "published_display": "02 Jul 2026 19:39", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial", "summary": "Mdxhealth announced the peer-reviewed publication of the Oxford GPS-ProMPT study in European Urology Oncology, a significant milestone for their collaboration with the University of Oxford. This study provides the scientific foundation for the ongoing GPS-ProtecT randomized clini", "url": "https://www.manilatimes.net/2026/06/29/tmt-newswire/globenewswire/mdxhealth-announces-peer-reviewed-publication-of-oxford-gps-prompt-study-in-european-urology-oncology-establishing-scientific-foundation-for-the-landmark-gps-protect-randomized-controlled-trial/2374830/amp", "source_name": "The Manila Times", "published_at": "2026-06-29T14:39:37", "published_display": "29 Jun 2026 14:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mdxhealth study finds 92% six-year freedom from failure", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQMjA1RzdWTkVKbzM0U2VxX212d3BRRUdKckt3SG0tLS1Gd3ZLZDYwTDAtNU5rdTNtWHVVWGZ3VEJvWWNPSmxWNWhUMEhfOVktelFFNjFaMmRFYjV5RFdzNFlIRDhLcTE2b3Q1MURNcVRtc1NvcE5uTEVmb2hZUGxCejI1SnZMMTNmc3VTQThlZVFNdUpPMTBnai05VGNHTVMzYy1fN25ZNFVlUjhEQUh6RmJHVmR3VkxteEg4eTRtUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth S.A. Actuals & Estimates (NASDAQ:MDXH)", "summary": "The article provides an overview of MDxHealth SA's financial data, analyst estimates, and stock performance on NASDAQ. It covers current stock price, historical highs and lows, volatility, market capitalization, earnings reports, revenue, net income, and future forecasts. The com", "url": "https://www.tradingview.com/symbols/NASDAQ-MDXH/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T12:40:10", "published_display": "26 Jun 2026 12:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth S.A. Actuals & Estimates (SWB:O6C1)", "summary": "This article provides an overview of MDxHealth S.A. (SWB:O6C1) financial actuals and estimates, including its stock ticker, forecast, historical prices, and upcoming earnings reports. It details recent earnings, revenue, net income, EBITDA, and employee count, clarifying that the", "url": "https://www.tradingview.com/symbols/SWB-O6C1/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T08:39:32", "published_display": "26 Jun 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDXH Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for MDxHealth SA (MDXH) stock, including analyst price targets, current stock performance, and financial metrics. Analysts have given a max estimate of $5.00 and a min estimate of $1.00 for MDXH's future price, despite recent significant declines ", "url": "https://www.tradingview.com/symbols/NASDAQ-MDXH/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T00:11:54", "published_display": "26 Jun 2026 00:11", "sentiment": "negative", "sentiment_pct": 30, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of MDxHealth SA (MDXH), focusing on its support and resistance levels, key indicators, and moving averages. The stock is currently trading between a resistance of 0.67 and support of 0.30, suggesting suitability for range-bound swing tra", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdxh/technical", "source_name": "TradingKey", "published_at": "2026-06-24T12:40:10", "published_display": "24 Jun 2026 12:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDXH PE Ratio & Valuation, Is MDXH Overvalued", "summary": "MDxHealth SA (MDXH) is currently undervalued, with a forward PS ratio of 0.26 compared to its five-year average of 2.39. Its fair price is estimated to be between $1.47 and $3.82, suggesting it is undervalued by 65.01% relative to its current price of $0.51. The article also prov", "url": "https://intellectia.ai/en/stock/MDXH/valuation", "source_name": "Intellectia AI", "published_at": "2026-06-23T11:40:12", "published_display": "23 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for MDxHealth SA (MDXH), highlighting a current earnings forecast score of 7.67, ranking it 278 out of 389 in its industry. Analysts set an average price target of $7.00, with a consensus \"Buy\" rating based on 6 analysts. The report also", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdxh/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T10:09:12", "published_display": "18 Jun 2026 10:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article analyzes the financial health of MDxHealth SA (MDXH), noting its stable financial status and high operating efficiency. The company's current financial score is 7.20, ranking 141 out of 388 in its industry. MDxHealth SA reported a 12.74% year-over-year increase in qu", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdxh/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T09:10:25", "published_display": "18 Jun 2026 09:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "This article provides a risk assessment for MDxHealth SA (MDXH), noting its current risk assessment score of 2.78, ranking it 189 out of 388 in the Biotechnology & Medical Research industry. The company's beta of 0.56 indicates it tends to underperform during upward markets but e", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdxh/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-18T09:10:25", "published_display": "18 Jun 2026 09:10", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of MDxHealth SA (MDXH), listing its major individual and institutional holders and their respective proportions. It also presents a breakdown of shareholder types and institutional shareholding data over several quarters, highlightin", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdxh/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T06:10:06", "published_display": "18 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of MDxHealth SA (MDXH) from TradingKey, noting a current valuation score of 9.03, ranking it 65th out of 388 in the Biotechnology & Medical Research industry. The company's P/E ratio is reported as -0.86, showing a slight decrease from i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdxh/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T05:10:06", "published_display": "18 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Don M. Hardison granted 10,000 MDxHealth (MDXH) options at $0.76", "summary": "MDxHealth's director, Don M. Hardison, was granted 10,000 share options at an exercise price of $0.76 per share, effective June 1, 2026. These compensation-related options vest in full at the annual general shareholders' meeting in the calendar year following the grant and expire", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-bf125cb18304.html", "source_name": "Stock Titan", "published_at": "2026-06-04T16:09:59", "published_display": "04 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (NASDAQ: MDXH) CEO granted 942,200 share options at $0.76 strike", "summary": "MDxHealth SA CEO Michael McGarrity was granted two share option awards totaling 942,200 options, each exercisable at $0.76 per share and expiring on May 28, 2036. One grant of 612,400 options vests based on Company performance criteria, while the other grant of 329,800 options ve", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-411cdbe9c02d.html", "source_name": "Stock Titan", "published_at": "2026-06-04T03:39:21", "published_display": "04 Jun 2026 03:39", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) director Koen Hoffman awarded 10,000 share options via Ahok BV", "summary": "MDxHealth director Koen Hoffman was granted 10,000 share options through his indirect holding company, Ahok BV, as reported in a Form 4 filing. These options, exercisable at $0.76 per share and expiring on May 28, 2036, are a compensation-related award and will vest fully on the ", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-df089767b040.html", "source_name": "Stock Titan", "published_at": "2026-06-04T03:39:21", "published_display": "04 Jun 2026 03:39", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) director Michael Holder receives 10,000 share option grant", "summary": "Michael Holder, a director at MDxHealth SA (MDXH), has been granted options to purchase 10,000 ordinary shares as part of an equity incentive award. The options have an exercise price of $0.76 per share and will vest in full on the date of the annual general shareholders' meeting", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-9a9a660833c3.html", "source_name": "Stock Titan", "published_at": "2026-06-03T22:09:53", "published_display": "03 Jun 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (NASDAQ: MDXH) grants Joseph Sollee 237,100 share options", "summary": "MDxHealth SA officer Joseph Sollee has been granted 237,100 share options, split into two grants, as equity compensation. Both grants have an exercise price of $0.76 per share and expire in 2036. One grant of 154,100 options vests based on company performance criteria, while the ", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-43f848ce2302.html", "source_name": "Stock Titan", "published_at": "2026-06-03T21:09:53", "published_display": "03 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) awards new share options to finance VP", "summary": "MDxHealth SA's VP of Finance and Accounting, Brendan O'Connell, was granted two sets of share options: 65,000 performance-based options and 35,000 time-based options, both at an exercise price of $0.76 per share. This increases his derivative-based compensation. The performance-b", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-90cd544371ec.html", "source_name": "Stock Titan", "published_at": "2026-06-03T21:09:53", "published_display": "03 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) director granted options on 10,000 shares", "summary": "MDxHealth director Sanford Jay Siegel was granted options on 10,000 ordinary shares with an exercise price of $0.76 per share. These options are part of his compensation, vest in full at the annual general shareholders' meeting in the year after the grant, and expire on May 28, 2", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-84dd1f8ce03e.html", "source_name": "Stock Titan", "published_at": "2026-06-03T21:09:53", "published_display": "03 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) Edges Higher as Shares Test Key Resistance Near $0.81 - Insider Sentiment", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQLVJ6ZlNtaUdFc0paUDNTWHlHcWMyWU01NG45Yk5tTC16TDhWMmtFeUVJa1ZNcllhMGVhUTRqaVFwQXl3bjBUZmdidU1xdkZhQzh4V1NzbVIxNGJ5TDl5V0lJSC01OUdJNDcydEhYSnVkdWF5T2VhUXpscFpBWmtscDVBTUNyTkxKYk5BUGZQUjhhYUY2SnZRZnhhMEpLQnFLYzhieURHVU5UX2c?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) Slides 6.25% as Cancer Diagnostics Stock Tests Key Support Level - Order Block", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxObFRpamhCcmdfTjRlb0ZXYkZvNDg0cVFOWldzUGlrQk1hVloxTmNHSVVYTGFuR2ZGZmkySm1MeEtJX3lsSVA4Q25kd1F0b1E2eTVoY3dtaUZFU0sza0dEVmhpcC1NQzlJWXFJbFBmY3VRSEZaOU9fSFhXS2VSbzZGeFM0d1RkVWkzc3BaOWZHVHl1QURhdkxLRERQM2MzaUdpV3lhQm5lODhkQjEyM0VlWFA1Sy1CQktHVDEwUUZoLXdGamlBMWRDdw?oc=5", "source_name": "B\u00f6l\u00fcm Sonu Canavar\u0131", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: MDxHealth Q1 2026 sees significant stock drop amid earnings miss", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOWkVHT1RnSXVHbnl5ZzcydnZISXVMU0FUcWx6bVRXRzZsTVlfbDBNYXota3IxTHJKbzBZSHZnRWE2Y2ZlbGl2S3JsRml0SGhGLVNTRjl6X1RxbnFfOE5MYV8xblltdlVBZzJGdVNNT2VoU1dDY1BZV2I4OU4wVnFYLUtBN1Vybm1QS2xaM1RBOEFYX2hYV2hZUnNGQWpXUjh4WnRYUzVXYkhNVDBsU0Y3eFgzNnJwNXF0MVg4NWQ5MmlDY1VpWjBEalVJeFVvazZ1NExoWk5EREdENG1abmc?oc=5", "source_name": "Investing.com", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TD Cowen cuts MDxHealth stock price target on Medicare dispute", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOZWxibm5keFVKNVYwa1psbDA3NW55ZVYyRFl5aG5QdnBJZ2Y1Vk00elNPMUpNRThlSzczTTl2eGF2dFQ1QVY2MkdfZ19BZGVRNl9mUE5YNkVraGtMSS0ySHA4cDE2enlXeVZCbFZzdjJBTTdOZTJIVnpDcHgwYUVlQ3hGY0lkY1FZRXFIQlgzemlETmdEM0hkUlo2dDFSbExseDZuek1xM0JhYjFab0Vvb3pHV1YwU0VpTXNWZWxhSQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) Q1 Loss Near US$8.9 Million Reinforces Bearish Profitability Concerns", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Focus Amid ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/mdxhealth-sa-mdxh-q1-2026-050244724.html", "source_name": "GuruFocus.com", "published_at": "2026-05-14T05:02:44+00:00", "published_display": "14 May 2026 05:02", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/75052401-cb1b-3d95-a0fb-15a19beebd9b/mdxhealth-%28mdxh%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-14T02:28:51+00:00", "published_display": "14 May 2026 02:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/b9ebdbd7-cfef-3e8d-bc29-afe00fb0fa8b/mdxhealth-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-14T02:06:03+00:00", "published_display": "14 May 2026 02:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth Reports Q1 2026 Results: Full Earnings Call Transcript", "summary": "", "url": "https://finance.yahoo.com/news/mdxhealth-reports-q1-2026-results-210819228.html", "source_name": "Benzinga", "published_at": "2026-05-13T21:08:19+00:00", "published_display": "13 May 2026 21:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth Q1 Loss Narrows, Revenue Rises", "summary": "", "url": "https://finance.yahoo.com/news/mdxhealth-q1-loss-narrows-revenue-204208704.html", "source_name": "MT Newswires", "published_at": "2026-05-13T20:42:08+00:00", "published_display": "13 May 2026 20:42", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mdxhealth Reports Q1-2026 Results", "summary": "", "url": "https://finance.yahoo.com/news/mdxhealth-reports-q1-2026-results-200000016.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T20:00:00+00:00", "published_display": "13 May 2026 20:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Expect Breakeven For MDxHealth SA (NASDAQ:MDXH) Before Long", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Loss-Making MDxHealth SA (NASDAQ:MDXH) Expected To Breakeven In The Medium-Term", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQNVV0RDZJNFVScWJKTUxSSmQ2MnBleFhZSHptRDdIdnZhcG92Q3FJMHFhNXI0dE1iZk5teThKdlRwck1nU3dqUkp2VnpfWVUtNTVXcFBmOGpabmxpR21JYUdSVXcxeDZmNm03TEVZcHpWTVo4ZWJBcFJJaVRaeXE3d29iUQ?oc=5", "source_name": "Market source", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (NASDAQ:MDXH) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-02T08:00:00+00:00", "published_display": "02 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA's (NASDAQ:MDXH) market cap touched US$182m last week, benefiting both individual investors who own 46% as well as institutions", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-28T08:00:00+00:00", "published_display": "28 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "AWM amendment: no MDxHealth holdings reported (MDXH)", "summary": "AWM Investment Company, Inc. has filed an amendment to a Schedule 13G/A, reporting that it holds no beneficial ownership in MDxHealth (MDXH). The filing indicates that AWM and its associated funds own 0 shares, representing 0% of the class of Common Stock, No Par Value (CUSIP B59", "url": "https://www.stocktitan.net/sec-filings/MDXH/schedule-13g-a-m-dx-health-sa-amended-passive-investment-disclosure-a7e70e1e04f3.html", "source_name": "Stock Titan", "published_at": "2026-07-08T20:09:58", "published_display": "08 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of MDxHealth SA \u2013 NASDAQ:MDXH", "summary": "This article provides financial information for MDxHealth SA (NASDAQ: MDXH), focusing on its enterprise value to revenue forward metric. The content highlights the availability of financial data through TradingView, noting market status and data sources. It appears to be a stub o", "url": "https://www.tradingview.com/symbols/NASDAQ-MDXH/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T19:43:12", "published_display": "07 Jul 2026 19:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA explores US growth opportunities as diagnostics demand evolves", "summary": "MDxHealth SA, a molecular diagnostics company specializing in urology and prostate cancer testing, is focused on expanding its presence in the US market. The company seeks to increase the adoption of its diagnostic assays among physicians and health systems to support precision m", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/mdxhealth-sa-explores-us-growth-opportunities-as-diagnostics-demand/69714934", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T14:40:19", "published_display": "07 Jul 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of MDxHealth SA \u2013 NASDAQ:MDXH", "summary": "This article provides financial data for MDxHealth SA (NASDAQ: MDXH), specifically its price-to-book forward ratio. The content is presented within the context of TradingView's market analysis platform, indicating that the information is part of a larger financial overview for th", "url": "https://www.tradingview.com/symbols/NASDAQ-MDXH/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T04:40:34", "published_display": "05 Jul 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of MDxHealth SA \u2013 NASDAQ:MDXH", "summary": "The article focuses on the \"Price to sales forward\" metric for MDxHealth SA, traded on NASDAQ under the symbol MDXH. It appears to be a financial data snippet from TradingView, highlighting this specific financial ratio for the company. The content primarily lists navigation and ", "url": "https://www.tradingview.com/symbols/NASDAQ-MDXH/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T02:10:35", "published_display": "05 Jul 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency", "summary": "Mdxhealth SA announced it received a notification from Nasdaq due to non-compliance with the minimum bid price requirement of US$1.00 per share. The company has 180 calendar days, until December 28, 2026, to regain compliance by having its shares close at or above US$1.00 for at ", "url": "https://www.manilatimes.net/2026/07/03/tmt-newswire/globenewswire/mdxhealth-announces-receipt-of-nasdaq-notification-regarding-minimum-bid-price-deficiency/2377799", "source_name": "The Manila Times", "published_at": "2026-07-03T16:40:51", "published_display": "03 Jul 2026 16:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mdxhealth receives NASDAQ non-compliance notice after $1 bid price breach", "summary": "Mdxhealth (MDXH) has received a notice from NASDAQ for non-compliance with its minimum bid price requirement, as its stock traded below $1 for 30 consecutive business days. The company has 180 calendar days, until June 30, 2024, to regain compliance by ensuring its stock trades a", "url": "https://www.msn.com/en-us/money/companies/mdxhealth-receives-nasdaq-non-compliance-notice-after-1-bid-price-breach/ar-AA275NiY?ocid=finance-verthp-feeds", "source_name": "MSN", "published_at": "2026-07-02T22:39:26", "published_display": "02 Jul 2026 22:39", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth Gets Nasdaq Non-Compliance Notice", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/mdxhealth-gets-nasdaq-non-compliance-201243372.html", "source_name": "MT Newswires", "published_at": "2026-07-02T20:12:43+00:00", "published_display": "02 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nasdaq warns mdxhealth (NASDAQ: MDXH) on $1 bid rule, eyes reverse split", "summary": "Mdxhealth (NASDAQ: MDXH) has received a notice from Nasdaq for non-compliance with the minimum $1.00 bid price requirement, as its shares traded below this threshold for 30 consecutive days. The company has 180 calendar days, until December 28, 2026, to regain compliance by maint", "url": "https://www.stocktitan.net/sec-filings/MDXH/6-k-m-dx-health-sa-current-report-foreign-issuer-dc1475b28776.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:39:26", "published_display": "02 Jul 2026 20:39", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mdxhealth gets 180 days to fix Nasdaq bid-price issue", "summary": "Mdxhealth (NASDAQ: MDXH) received a Nasdaq notification on New Year's Eve 2026, indicating its shares no longer meet the US$1.00 minimum bid price requirement for continued listing. The company has 180 days, until December 28, 2026, to regain compliance, and may consider options ", "url": "https://www.stocktitan.net/news/MDXH/mdxhealth-announces-receipt-of-nasdaq-notification-regarding-minimum-3x328ywzexo6.html", "source_name": "Stock Titan", "published_at": "2026-07-02T19:39:26", "published_display": "02 Jul 2026 19:39", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial", "summary": "Mdxhealth announced the peer-reviewed publication of the Oxford GPS-ProMPT study in European Urology Oncology, a significant milestone for their collaboration with the University of Oxford. This study provides the scientific foundation for the ongoing GPS-ProtecT randomized clini", "url": "https://www.manilatimes.net/2026/06/29/tmt-newswire/globenewswire/mdxhealth-announces-peer-reviewed-publication-of-oxford-gps-prompt-study-in-european-urology-oncology-establishing-scientific-foundation-for-the-landmark-gps-protect-randomized-controlled-trial/2374830/amp", "source_name": "The Manila Times", "published_at": "2026-06-29T14:39:37", "published_display": "29 Jun 2026 14:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mdxhealth study finds 92% six-year freedom from failure", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQMjA1RzdWTkVKbzM0U2VxX212d3BRRUdKckt3SG0tLS1Gd3ZLZDYwTDAtNU5rdTNtWHVVWGZ3VEJvWWNPSmxWNWhUMEhfOVktelFFNjFaMmRFYjV5RFdzNFlIRDhLcTE2b3Q1MURNcVRtc1NvcE5uTEVmb2hZUGxCejI1SnZMMTNmc3VTQThlZVFNdUpPMTBnai05VGNHTVMzYy1fN25ZNFVlUjhEQUh6RmJHVmR3VkxteEg4eTRtUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth S.A. Actuals & Estimates (NASDAQ:MDXH)", "summary": "The article provides an overview of MDxHealth SA's financial data, analyst estimates, and stock performance on NASDAQ. It covers current stock price, historical highs and lows, volatility, market capitalization, earnings reports, revenue, net income, and future forecasts. The com", "url": "https://www.tradingview.com/symbols/NASDAQ-MDXH/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T12:40:10", "published_display": "26 Jun 2026 12:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth S.A. Actuals & Estimates (SWB:O6C1)", "summary": "This article provides an overview of MDxHealth S.A. (SWB:O6C1) financial actuals and estimates, including its stock ticker, forecast, historical prices, and upcoming earnings reports. It details recent earnings, revenue, net income, EBITDA, and employee count, clarifying that the", "url": "https://www.tradingview.com/symbols/SWB-O6C1/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T08:39:32", "published_display": "26 Jun 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDXH Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for MDxHealth SA (MDXH) stock, including analyst price targets, current stock performance, and financial metrics. Analysts have given a max estimate of $5.00 and a min estimate of $1.00 for MDXH's future price, despite recent significant declines ", "url": "https://www.tradingview.com/symbols/NASDAQ-MDXH/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T00:11:54", "published_display": "26 Jun 2026 00:11", "sentiment": "negative", "sentiment_pct": 30, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of MDxHealth SA (MDXH), focusing on its support and resistance levels, key indicators, and moving averages. The stock is currently trading between a resistance of 0.67 and support of 0.30, suggesting suitability for range-bound swing tra", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdxh/technical", "source_name": "TradingKey", "published_at": "2026-06-24T12:40:10", "published_display": "24 Jun 2026 12:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDXH PE Ratio & Valuation, Is MDXH Overvalued", "summary": "MDxHealth SA (MDXH) is currently undervalued, with a forward PS ratio of 0.26 compared to its five-year average of 2.39. Its fair price is estimated to be between $1.47 and $3.82, suggesting it is undervalued by 65.01% relative to its current price of $0.51. The article also prov", "url": "https://intellectia.ai/en/stock/MDXH/valuation", "source_name": "Intellectia AI", "published_at": "2026-06-23T11:40:12", "published_display": "23 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for MDxHealth SA (MDXH), highlighting a current earnings forecast score of 7.67, ranking it 278 out of 389 in its industry. Analysts set an average price target of $7.00, with a consensus \"Buy\" rating based on 6 analysts. The report also", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdxh/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T10:09:12", "published_display": "18 Jun 2026 10:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article analyzes the financial health of MDxHealth SA (MDXH), noting its stable financial status and high operating efficiency. The company's current financial score is 7.20, ranking 141 out of 388 in its industry. MDxHealth SA reported a 12.74% year-over-year increase in qu", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdxh/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T09:10:25", "published_display": "18 Jun 2026 09:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "This article provides a risk assessment for MDxHealth SA (MDXH), noting its current risk assessment score of 2.78, ranking it 189 out of 388 in the Biotechnology & Medical Research industry. The company's beta of 0.56 indicates it tends to underperform during upward markets but e", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdxh/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-18T09:10:25", "published_display": "18 Jun 2026 09:10", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of MDxHealth SA (MDXH), listing its major individual and institutional holders and their respective proportions. It also presents a breakdown of shareholder types and institutional shareholding data over several quarters, highlightin", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdxh/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T06:10:06", "published_display": "18 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of MDxHealth SA (MDXH) from TradingKey, noting a current valuation score of 9.03, ranking it 65th out of 388 in the Biotechnology & Medical Research industry. The company's P/E ratio is reported as -0.86, showing a slight decrease from i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-mdxh/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T05:10:06", "published_display": "18 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Don M. Hardison granted 10,000 MDxHealth (MDXH) options at $0.76", "summary": "MDxHealth's director, Don M. Hardison, was granted 10,000 share options at an exercise price of $0.76 per share, effective June 1, 2026. These compensation-related options vest in full at the annual general shareholders' meeting in the calendar year following the grant and expire", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-bf125cb18304.html", "source_name": "Stock Titan", "published_at": "2026-06-04T16:09:59", "published_display": "04 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (NASDAQ: MDXH) CEO granted 942,200 share options at $0.76 strike", "summary": "MDxHealth SA CEO Michael McGarrity was granted two share option awards totaling 942,200 options, each exercisable at $0.76 per share and expiring on May 28, 2036. One grant of 612,400 options vests based on Company performance criteria, while the other grant of 329,800 options ve", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-411cdbe9c02d.html", "source_name": "Stock Titan", "published_at": "2026-06-04T03:39:21", "published_display": "04 Jun 2026 03:39", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) director Koen Hoffman awarded 10,000 share options via Ahok BV", "summary": "MDxHealth director Koen Hoffman was granted 10,000 share options through his indirect holding company, Ahok BV, as reported in a Form 4 filing. These options, exercisable at $0.76 per share and expiring on May 28, 2036, are a compensation-related award and will vest fully on the ", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-df089767b040.html", "source_name": "Stock Titan", "published_at": "2026-06-04T03:39:21", "published_display": "04 Jun 2026 03:39", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) director Michael Holder receives 10,000 share option grant", "summary": "Michael Holder, a director at MDxHealth SA (MDXH), has been granted options to purchase 10,000 ordinary shares as part of an equity incentive award. The options have an exercise price of $0.76 per share and will vest in full on the date of the annual general shareholders' meeting", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-9a9a660833c3.html", "source_name": "Stock Titan", "published_at": "2026-06-03T22:09:53", "published_display": "03 Jun 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (NASDAQ: MDXH) grants Joseph Sollee 237,100 share options", "summary": "MDxHealth SA officer Joseph Sollee has been granted 237,100 share options, split into two grants, as equity compensation. Both grants have an exercise price of $0.76 per share and expire in 2036. One grant of 154,100 options vests based on company performance criteria, while the ", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-43f848ce2302.html", "source_name": "Stock Titan", "published_at": "2026-06-03T21:09:53", "published_display": "03 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) awards new share options to finance VP", "summary": "MDxHealth SA's VP of Finance and Accounting, Brendan O'Connell, was granted two sets of share options: 65,000 performance-based options and 35,000 time-based options, both at an exercise price of $0.76 per share. This increases his derivative-based compensation. The performance-b", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-90cd544371ec.html", "source_name": "Stock Titan", "published_at": "2026-06-03T21:09:53", "published_display": "03 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) director granted options on 10,000 shares", "summary": "MDxHealth director Sanford Jay Siegel was granted options on 10,000 ordinary shares with an exercise price of $0.76 per share. These options are part of his compensation, vest in full at the annual general shareholders' meeting in the year after the grant, and expire on May 28, 2", "url": "https://www.stocktitan.net/sec-filings/MDXH/form-4-m-dx-health-sa-insider-trading-activity-84dd1f8ce03e.html", "source_name": "Stock Titan", "published_at": "2026-06-03T21:09:53", "published_display": "03 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) Edges Higher as Shares Test Key Resistance Near $0.81 - Insider Sentiment", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQLVJ6ZlNtaUdFc0paUDNTWHlHcWMyWU01NG45Yk5tTC16TDhWMmtFeUVJa1ZNcllhMGVhUTRqaVFwQXl3bjBUZmdidU1xdkZhQzh4V1NzbVIxNGJ5TDl5V0lJSC01OUdJNDcydEhYSnVkdWF5T2VhUXpscFpBWmtscDVBTUNyTkxKYk5BUGZQUjhhYUY2SnZRZnhhMEpLQnFLYzhieURHVU5UX2c?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) Slides 6.25% as Cancer Diagnostics Stock Tests Key Support Level - Order Block", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxObFRpamhCcmdfTjRlb0ZXYkZvNDg0cVFOWldzUGlrQk1hVloxTmNHSVVYTGFuR2ZGZmkySm1MeEtJX3lsSVA4Q25kd1F0b1E2eTVoY3dtaUZFU0sza0dEVmhpcC1NQzlJWXFJbFBmY3VRSEZaOU9fSFhXS2VSbzZGeFM0d1RkVWkzc3BaOWZHVHl1QURhdkxLRERQM2MzaUdpV3lhQm5lODhkQjEyM0VlWFA1Sy1CQktHVDEwUUZoLXdGamlBMWRDdw?oc=5", "source_name": "B\u00f6l\u00fcm Sonu Canavar\u0131", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: MDxHealth Q1 2026 sees significant stock drop amid earnings miss", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOWkVHT1RnSXVHbnl5ZzcydnZISXVMU0FUcWx6bVRXRzZsTVlfbDBNYXota3IxTHJKbzBZSHZnRWE2Y2ZlbGl2S3JsRml0SGhGLVNTRjl6X1RxbnFfOE5MYV8xblltdlVBZzJGdVNNT2VoU1dDY1BZV2I4OU4wVnFYLUtBN1Vybm1QS2xaM1RBOEFYX2hYV2hZUnNGQWpXUjh4WnRYUzVXYkhNVDBsU0Y3eFgzNnJwNXF0MVg4NWQ5MmlDY1VpWjBEalVJeFVvazZ1NExoWk5EREdENG1abmc?oc=5", "source_name": "Investing.com", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TD Cowen cuts MDxHealth stock price target on Medicare dispute", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOZWxibm5keFVKNVYwa1psbDA3NW55ZVYyRFl5aG5QdnBJZ2Y1Vk00elNPMUpNRThlSzczTTl2eGF2dFQ1QVY2MkdfZ19BZGVRNl9mUE5YNkVraGtMSS0ySHA4cDE2enlXeVZCbFZzdjJBTTdOZTJIVnpDcHgwYUVlQ3hGY0lkY1FZRXFIQlgzemlETmdEM0hkUlo2dDFSbExseDZuek1xM0JhYjFab0Vvb3pHV1YwU0VpTXNWZWxhSQ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) Q1 Loss Near US$8.9 Million Reinforces Bearish Profitability Concerns", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (MDXH) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Focus Amid ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/mdxhealth-sa-mdxh-q1-2026-050244724.html", "source_name": "GuruFocus.com", "published_at": "2026-05-14T05:02:44+00:00", "published_display": "14 May 2026 05:02", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth (MDXH) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/75052401-cb1b-3d95-a0fb-15a19beebd9b/mdxhealth-%28mdxh%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-14T02:28:51+00:00", "published_display": "14 May 2026 02:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/b9ebdbd7-cfef-3e8d-bc29-afe00fb0fa8b/mdxhealth-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-14T02:06:03+00:00", "published_display": "14 May 2026 02:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth Reports Q1 2026 Results: Full Earnings Call Transcript", "summary": "", "url": "https://finance.yahoo.com/news/mdxhealth-reports-q1-2026-results-210819228.html", "source_name": "Benzinga", "published_at": "2026-05-13T21:08:19+00:00", "published_display": "13 May 2026 21:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth Q1 Loss Narrows, Revenue Rises", "summary": "", "url": "https://finance.yahoo.com/news/mdxhealth-q1-loss-narrows-revenue-204208704.html", "source_name": "MT Newswires", "published_at": "2026-05-13T20:42:08+00:00", "published_display": "13 May 2026 20:42", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mdxhealth Reports Q1-2026 Results", "summary": "", "url": "https://finance.yahoo.com/news/mdxhealth-reports-q1-2026-results-200000016.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T20:00:00+00:00", "published_display": "13 May 2026 20:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Expect Breakeven For MDxHealth SA (NASDAQ:MDXH) Before Long", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxPeHVMcHpGaERSMmtTdERRcTdlMEMwd3NaN2RWM1NQaERMVzYxRDkyMDYyaERaZWJwUDlEWDcwUUc3NHZRODdOcllsb0RaZmJ1RjdEUWNDQ19SQUJ2QTJIWUhfak5lb0U5S3dhUVpfWGo4QXBzbkk5WEJHWFB3dUEzNEVSbGFfcWx1NFRiVkx2ckZhN2EycnlLX0VSYS13enk5R1ZRczNRcjVpVTRHMUxES2lDYU5fMXljcERNaWVweDdBTGx4RFdaUHRMYXNGcktkUXE4WDZIVXVkLUHSAeABQVVfeXFMT1hCYTFoeUcwNW96WllxZFE2NGlXazVzODllNzdsSFRlOXNxNVE0SC11c1E5ZTVHbWlGTVFfNUVYbndnVDJPYmZnSzVjcENqM0RBUkxIdTlzcXNRYXRBM1R2eXdBUGVHRkEyLWU5ampOMjZURXVfX0FldWxTdTMtOXA5Y1J3bFpsaUFmaF9xZTJydjVMUUktYTZmX0lRNElQMTA4ZENjb19zMWhKYThqblNWRzZsM3pHMC1idFY3ejNmM3pCLUFsYzJOWDJCU3dDeUV0Ty1RMVlJbUcxQlc1RnI?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Loss-Making MDxHealth SA (NASDAQ:MDXH) Expected To Breakeven In The Medium-Term", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQNVV0RDZJNFVScWJKTUxSSmQ2MnBleFhZSHptRDdIdnZhcG92Q3FJMHFhNXI0dE1iZk5teThKdlRwck1nU3dqUkp2VnpfWVUtNTVXcFBmOGpabmxpR21JYUdSVXcxeDZmNm03TEVZcHpWTVo4ZWJBcFJJaVRaeXE3d29iUQ?oc=5", "source_name": "Market source", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA (NASDAQ:MDXH) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-02T08:00:00+00:00", "published_display": "02 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MDxHealth SA's (NASDAQ:MDXH) market cap touched US$182m last week, benefiting both individual investors who own 46% as well as institutions", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOSWplUW5LR1BwRGx4RTlsRTJBNUpweVpVdEE2VnZ3aDBuYi1qV3M5YTREZUYzQTA2TTkwai1kLXJGYkFReVA2dTR2eVd5WXF6RzU4TGhxbGpQTmVDcW9Oa2JhZGlHVmc5ZjY5NHpxQUF1VFgzcnJYVmxRNWhMTE43RG1GUDhBTHBhMlo5bVoyZVVBOXQtZjJaMElybkt2Yko2ZXh5TUhBQkt4a2FHaUMtbkZOcWIxQmN5aTNNYWRWTXZoaDZkVHhBczBldkZvN2dpc2FvcG1WVGJIaXfSAeABQVVfeXFMTU5CemhXNlBJY05lVFludHFJQjBOM1YtRWVVbDRRMG44MzFhRVdrbmpnM1FSdk42QXg4aThXZ1NOcEUyNkY4RER1SVVPTThDZ3FDd0VwVlNrRzVqdkZscGhPaTdSS0p2RkFRcHQ5XzhUYlRhYjJ5WGRHY3ZWQ1J5eElxQkJUQjMwVjFhQ1ByQUZRWV9yVXZ1bnJUYUdPanBIRG9rcTFvc2RWWXJLOE5aak5pRXNRbDBqZGtCX3hhdnVZVHVXQkV1M0xhSDljVEYtaGp2UDBlblgxb1oyT1lPUHE?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-28T08:00:00+00:00", "published_display": "28 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 44, "sentiment_summary": {"positive": 8, "negative": 12, "neutral": 24, "score": 48, "total": 44, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 15.95, "count": 29}, {"event": "earnings", "label": "Earnings", "weight": 6.05, "count": 11}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 8, "negative_events": 12}, "market_context": {"has_market_context": true, "latest_close": 0.48, "latest_week": "2026-07-10", "one_week_move": -0.1, "four_week_move": -12.2, "twelve_week_move": -79.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.216723, "market_dynamics_buy_signal": false, "relative_strength": -86.072261, "fair_value_gap": -82.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.4155, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.1% over one week, -12.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 51, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 11}, {"label": "TradingView", "count": 6}, {"label": "TradingKey", "count": 6}, {"label": "simplywall.st", "count": 4}, {"label": "The Manila Times", "count": 2}, {"label": "MT Newswires", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "AD HOC NEWS", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 44}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 29}, {"label": "Earnings", "count": 11}, {"label": "Analyst action", "count": 3}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "44", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.1% over one week, -12.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "AWM amendment: no MDxHealth holdings reported (MDXH)"}], "updated_at": "2026-07-17T10:08:22.108605+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}